BEDMINSTER, N.J.--(BUSINESS WIRE)--EKR Therapeutics, Inc. a privately held specialty pharmaceutical company, announced today that Rolf A. Classon, chairman of the board and independent director, will not stand for reelection and has resigned effective immediately.
